Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being ...

Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...

Pat Finn, known for his roles in Seinfeld and The Middle, has died at age 60 after a battle with bladder cancer. Fans and ...

Kolschowsky Research and Education Institute at Sarasota Memorial Hospital is seeking candidates diagnosed with ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.

Pat Finn, an actor best known for his roles on “Seinfeld” and “The Middle,” has died. Finn passed away Dec. 22, at age 60 of ...

Investigators studied US trends in the diagnosis of variant histology bladder cancer using the National Cancer database.

“PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility,” by Astellas Pharma Inc. News release; Dec. 17, 2025.

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

In December 2025, Astellas Pharma and Pfizer reported that their Phase 3 EV-304 trial of PADCEV plus Keytruda in muscle-invasive bladder cancer achieved statistically significant improvements in event ...